HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma Clinical Trials in Shanghai, Shanghai Municipality

SHR-A1811 for Subjects With Her2-positive Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on or After First-line Anti-HER2 Therapy-containing Regimen